A report released yesterday by the international medical humanitarian organization Medecins Sans Frontieres (MSF) revealed that several countries hardest hit by the AIDS epidemic are improving HIV treatment to reduce deaths and illness - but a lack of support from donors prevents many from making vital changes.
This fragile progress needs sustained support, but the two biggest AIDS donors, the USA and UK, are opposing a critical HIV treatment target ahead of next month’s United Nations AIDS Summit in New York at a time when mounting evidence shows that HIV treatment can also prevent HIV infections, claims MSF.
“Our report shows that there is clear engagement from countries to providing an ambitious response to AIDS, by changing their guidelines to put people on treatment earlier and with better drugs,” said Tido von Schoen-Angerer, executive director of MSF’s Access Campaign. “But, because of funding constraints, some of them are unable to put these guidelines into practice, which serves as a reminder of how fragile this progress really is,” he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze